About

Dr. Stephen R. Quake has served on AbCellera's Board of Directors since November 2025 and is a member of the Audit Committee and the Nominating and Corporate Governance Committee. He has been a professor at Stanford University since 2005, where he is the Lee Otterson Professor of Bioengineering and Professor of Applied Physics, and is a prolific inventor in DNA sequencing and microfluidic automation whose work contributed to non-invasive prenatal testing. He serves on the boards of Tachyon Therapeutics, IgGenix, Superfluid DX, ClearNote Health, Kanvas and Mirvie. He holds a B.S. in Physics and an M.S. in Mathematics from Stanford University and a D.Phil. in Theoretical Physics from the University of Oxford.

Roles

AbCellera Biologics Inc.
Director · Current role
November 2025–present
Stanford University
Lee Otterson Professor of Bioengineering and Professor of Applied Physics
2005 - present
CM Life Sciences II / SomaLogic
Director
2020 - 2022

External Roles

Tachyon Therapeutics
Director
IgGenix Inc.
Director
Mirvie
Director
ClearNote Health
Director

Director Compensation

FY 2025
Fees earned or paid in cash
$10,575
ComponentBoard and committee cash retainers, prorated for FY2025 service
Option awards
$426,916
ComponentAnnual stock option grant, ASC 718 grant-date fair value
Total
$437,491
NoteAppointed to the Board November 6, 2025; compensation prorated and includes the new-director equity grant

Also at AbCellera Biologics Inc.

Related

See how VectorShift works for your firm

Request Demo